Viewing Study NCT02420366


Ignite Creation Date: 2025-12-24 @ 4:35 PM
Ignite Modification Date: 2026-02-08 @ 8:39 AM
Study NCT ID: NCT02420366
Status: COMPLETED
Last Update Posted: 2018-05-02
First Post: 2015-04-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae
Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: Rempex 506 NH
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators